AL
Alivus Life Sciences Ltd.
ALIVUS.NS · NSE
₹1,362.00 +1.05% (+₹14.20)
1M -3.34%
Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.05x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ALIVUS.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yasir Yusufali Rawjee
Employees
2,272
Headquarters
Mumbai
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report